USP9X promotes lipopolysaccharide-stimulated acute lung injury by deubiquitination of NLRP3
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Alveolar epithelial cells (AECs) function as a vital defense barrier avoiding the invasion of exogenous agents and preserving the functional and structural integrity of lung tissues, while damage/breakdown of this airway epithelial barrier is frequently associated with the pathogenesis of acute lung injury (ALI). NOD‐like receptor family, pyrindomain‐containing 3 (NLRP3) inflammasome activation‐associated pyroptosis is involved in the development of ALI. Yet, how the activity of NLRP3 inflammasome is regulated in the context of ALI remains unknown. Herein we hypothesized that USP9X, an important deubiquitinase, participates in modulating the activation of NLRP3 inflammasome, thereby affecting the phenotypes in a lipopolysaccharide (LPS)‐stimulated AEC model. Human pulmonary AECs were subjected to LPS/adenosine triphosphate (ATP) treatment to induce NLRP3 inflammasome activation and cell pyroptosis. Knockdown and overexpression of USP9X were applied to validate the function of USP9X. Inhibitors of proteinase and protein synthesis, as well as approach of co‐immunoprecipitation coupled with Western blot, were utilized to explore the molecular mechanism. LPS/ATP challenge resulted in pronouncedly increased pyroptosis of AECs, activation of NLRP3 inflammasome and release of interleukin (IL)‐1β and IL‐18 cytokines, while downregulation of USP9X could reverse these alterations. USP9X was found to have marked impact on NLRP3 protein instead of mRNA level. Furthermore, increased ubiquitination of NLRP3 was observed upon downregulating USP9X. Additionally, the inhibitory effect of USP9X downregulation was reversed by NLRP3 overexpression, while the promoting impact of USP9X overexpression was dampened by NLRP3 inhibitor in terms of cell pyroptosis and cytokine secretion. USP9X modulated the activity of NLRP3 inflammasome and pyroptosis of AECs via its deubiquitination function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins include the deubquitinases USP9X (42) and USP8 (43), as well as the kinases PTK2B (44), ADK (45), and RIPK3 (46).”
From Thermal Proteome Profiling Reveals Meltome Upon NLRP3 Inflammasome Activation (2025) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wree, A., Eguchi, A., McGeough, M. D., Pena, C. A., Johnson, C. D., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Hepatology · doi:10.1002/hep.26592 · Cited by 945
Yanagi, S., Tsubouchi, H., Miura, A., Matsumoto, N., & Nakazato, M. (2015) · BioMed Research International · doi:10.1155/2015/573210 · Cited by 71
Research works printed but not linked: 43
- 10.1038/ni.3772 · DOI · Paper page
- 10.1007/s10753-021-01428-9 · DOI
- 10.1152/ajplung.00361.2009 · DOI · Paper page
- 10.1038/nature08938 · DOI · Paper page
- 10.1016/j.resp.2020.103532 · DOI
- 10.1038/ng756 · DOI · Paper page
- 10.1016/j.freeradbiomed.2021.01.045 · DOI
- 10.1080/15548627.2016.1230584 · DOI · Paper page
- 10.1089/jir.2019.0083 · DOI
- 10.1080/01902148.2016.1267823 · DOI
- 10.1016/j.molimm.2019.04.023 · DOI
- 10.4049/jimmunol.178.8.5271 · DOI · Paper page
- 10.1016/j.intimp.2021.107419 · DOI
- 10.1186/s12964-020-00688-6 · DOI
- 10.3390/cells10123425 · DOI
- Liu Y., 2020, Hypoxia‐inducible factor‐1: A potential target to treat acute lung injury, Oxidative Medicine and Cellular Longevity, 2020, 1, 10.1155/2020/8871476 · DOI
- 10.1111/febs.15118 · DOI
- 10.1111/j.1600-065X.2011.01044.x · DOI · Paper page
- 10.1007/s00018-015-1851-0 · DOI · Paper page
- 10.1016/j.intimp.2019.106024 · doi:10.1016/j.intimp.2019.106024
- 10.15252/embr.201744766 · DOI · Paper page
- 10.1128/JVI.00022-18 · DOI
- 10.1128/Spectrum.00755-21 · DOI
- 10.1038/ni.2237 · DOI · Paper page
- 10.15252/embj.2018100376 · DOI
- 10.1038/ncomms7574 · DOI · Paper page
- 10.1016/j.bbrc.2020.07.126 · DOI
- 10.1074/jbc.RA119.007655 · DOI
- 10.1152/ajplung.00526.2020 · DOI
- 10.3389/fimmu.2018.01054 · DOI
- 10.1038/ncomms13727 · DOI · Paper page
- 10.1038/s41577-019-0165-0 · DOI · Paper page
- 10.1084/jem.20182091 · DOI · Paper page
- Tang Z., 2021, Apurinic/apyrimidinic endonuclease 1/reduction‐oxidation effector factor‐1 (APE1) regulates the expression of NLR family pyrin domain containing 3 (NLRP3) inflammasome through modulating transcription factor NF‐κB and promoting the secretion of inflammatory mediators in macrophages, Annals of Translational Medicine, 9, 145, 10.21037/atm-20-7752 · DOI
- 10.1038/nm.2279 · DOI · Paper page
- 10.1016/j.redox.2021.101878 · DOI
- 10.1186/s12890-018-0735-0 · DOI
- 10.1152/ajpcell.00094.2019 · DOI
- 10.1152/ajplung.00190.2018 · DOI
- 10.1371/journal.ppat.1005121 · DOI
- 10.1016/j.neuron.2019.11.003 · DOI
- 10.1038/s41420-022-00872-2 · DOI
- Zhao L. R., 2018, NLRP1 and NLRP3 inflammasomes mediate LPS/ATP‑induced pyroptosis in knee osteoarthritis, Molecular Medicine Reports, 17, 5463
Cited by
Thermal Proteome Profiling Reveals Meltome Upon NLRP3 Inflammasome Activation
Yang, C., Wang, L., Liu, Y., Zhang, Y., Jin, C., Cheng, J., Shang, L., Fang, L., Wu, S., Chen, C., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100972 · Cited by 3
Metadata
- Authors
- Xiang, Y., Li, X., Cai, M., & Cai, D.
- Affiliations
- Development Project of Shanghai Peak Disciplines‐Integrative Medicine, Department of Integrative Medicine, Zhongshan Hospital, Institutes of Integrative Medicine Fudan University Shanghai China
- ORCID
- Xiang, Yijin
- Venue
- Cell Biology International
- Publisher
- Wiley
- Published
- 2022-12-16
- Volume
- 47
- Issue
- 2
- Pages
- 394-405
- ISSN
- 1065-6995
- 1095-8355
- Cited by
- 25
- References
- 2
- Language
- en
- Funders
- National Natural Science Foundation of China (82004123)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.